Aptose Announces Results from Special Meeting of Shareholders

2 weeks ago

SAN DIEGO and TORONTO, Sept. 05, 2024 ( GLOBE NEWSWIRE ) -- Aptose Biosciences Inc. ( "Aptose" or the "Company" ) ( NASDAQ: APTO, TSX: APS ) , a clinical-stage precision oncology company developing tuspetinib, a highly differentiated oral kinase inhibitor for the treatment of patients with acute ...

Ticker	Sentiment	Impact
APTO	Somewhat Bullish	29 %